1 ) Hyper-ammonia and amine-acid imbalance In chronic liver failure, hyper-ammonia and an increase of aromatic amineacids due to an imbalance of amineacid lead to hepatic encephalopathy. This type of hepatic encephalopathy should be treated by medical administration and then grade of come would be improved after treatment. Thus, this type of brain damagewill recover soon after liver transplantation.
2) Brain edema due to hepatic encephalopathy On the contrary, hepatic encephalopathy occurring at fulminant hepatic failure as brain edemamight be difficult to judge as critical or not, because this type of encephalopathy occurred immediately after onset and rash to high grade of coma. It is thought that there is not have enough time to judge whether this type of encephalopathy will recover or becomeirreversible. This decision might be very important for the indication of liver transplantation. Several conditions of grade IV hepatic comado recover after liver transplantation in fulminant hepatic failure.
3) Bilirubin encephalopathy (Kernicterus)
Although, sudden signs of kernicterus could be reversed by prompt medical treatment, it is generally accepted that fullblownkernicterus is irreversible and this condition can not be expected to improve after liver transplantation (3).
Whatis an adequate marker and test before liver transplantation? (Table) Long-term hyperammonemia and hyprebilirubinemia disturb brain function, however, the major brain damage of hepatic encephalopathy occurring in fulminant hepatic failure is 2) Brain CT and MRImight be possible tools to detect the degree of brain edema. The majority of investigators reported that brain CT should be useful for the detection of brain edema and brain herniation (4-7). ... 3) Furthermore, most transplant institutes in Europe and USA use cadaveric liver transplantation with grade IV of hepatic coma and epidural monitor is valuable to guide treatment. The goals are to maintain an ICP of < 20 mmHg and a cerebral perfusion pressure (CPP) (CPP = mean arterial pressure -ICP) of >50 mmHg. The reason whymany Japanese institutes do not measure ICP prior to transplantation may be to avoid a hemorrhagic tendency in the epidural space. The consumption of coagulation protein due to fulminant hepatic failure often appears in this condition. The development of total imaging will be useful to evaluate and aid the diagnosis of brain edema in place of invasive procedures such as the measurementof ICP (8, 9) .
What do we do before liver transplantation? At cadaveric liver transplantation, if the ICP rises above 20 mmHg, patients are hyperventilated, or mannitol is administrated or pentobarbital is bolus injected. ICP monitoring provides reliable criteria for avoidance of orthotopic liver transplantation in-patients with irreversible brain damage and provides evidence of impending brain death. If diffuse brain edema is revealed by brain CT, liver transplantation should not be undertaken (7) . Therefore, brain edema must be improved with the use of multiple drugs to decrease ICP or improve the neurological findings on CT/MRI/SPECT.
With these treatments, if sufficient recovery of brain edema is not obtained, liver transplantation should be avoided. This is a significant point for clinical liver transplantation. In the journal, Kaneko et al reported recovery of bilirubin encephalopathy prior to liver transplantation and indicated complete recovery after transplantation without any chronic sequellae (12) . They pointed out an important message for reversible bilirubin encephalopathy. Bilirubin absorption treatment for this type of encephalopathy is useful to avoid brain damage after transplantation, because the majority with this type of encephalopathy suffers severe brain complications after transplantation, with or without previous treatment (3) . It might be difficult to judge the reversibility of brain damage before transplantation in acute hepatic failure, however, great clinical effort must be madeto evaluate and treat brain edema immediately to maintain a good quality of life after transplantation.
Current therapy for Crigler-Najjar syndrome type 1 Considering the treatment for Crigler-Najj ar syndrome type I, a multicenter survey indicated that liver transplantation is the only effective therapy (10, 1 1). However, a significant number of patients received liver transplantation after someform of brain damage and these patients suffered several grades of brain damage after transplantation (5/8; 62%). They concluded that liver transplantation should be performed at a young age, particularly in situations in which a reliable administration of phototherapy cannot be guaranteed (3). 
